Chromosome 18 transcriptome profiling and targeted proteome mapping in depleted plasma, liver tissue and HepG2 cells

Journal of Proteome Research

Volumn 12, Issue 1, 2013, Pages 123-134

  Zgoda, Victor G ^a   Kopylov, Arthur T ^a   Tikhonova, Olga V ^a   Moisa, Alexander A ^a   Pyndyk, Nadezhda V ^a   Farafonova, Tatyana E ^a   Novikova, Svetlana E ^a   Lisitsa, Andrey V ^a   Ponomarenko, Elena A ^a   Poverennaya, Ekaterina V ^a   Radko, Sergey P ^a   Khmeleva, Svetlana A ^a   Kurbatov, Leonid K ^a   Filimonov, Aleksey D ^a   Bogolyubova, Nadezhda A ^a   Ilgisonis, Ekaterina V ^a   Chernobrovkin, Aleksey L ^a   Ivanov, Alexis S ^a   Medvedev, Alexei E ^a   Mezentsev, Yury V ^a   Moshkovskii, Sergei A ^a   Naryzhny, Stanislav N ^a,b   Ilina, Elena N ^c   Kostrjukova, Elena S ^c   Alexeev, Dmitry G ^c   Tyakht, Alexander V ^c   Govorun, Vadim M ^c   Archakov, Alexander I ^a   more..

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^c FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

Chromosome 18; Human proteome project; Mass spectrometry; Selected reaction monitoring (SRM); Targeted proteomics

Indexed keywords

CYTOCHROME B5; PROTEOME; RNA; SEPHAROSE; TRANSCRIPTOME;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN HEPG2; CHROMOSOME 18; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MASS SPECTROMETRY; OPTICAL BIOSENSOR; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE;

BLOOD PROTEINS; CHROMOSOMES, HUMAN, PAIR 18; DATABASES, PROTEIN; GENE EXPRESSION; GENOME, HUMAN; HEP G2 CELLS; HUMANS; LIVER; MASS SPECTROMETRY; PROTEOME; TRANSCRIPTOME;

EID: 84874089699     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300821n     Document Type: Article

References (61)

1. Archakov, A.; Aseev, A.; Bykov, V.; Grigoriev, A.; Govorun, V.; Ivanov, V.; Khlunov, A.; Lisitsa, A.; Mazurenko, S.; Makarov, A. A.; Ponomarenko, E.; Sagdeev, R.; Skryabin, K. Gene-centric view on the human proteome project: the example of the Russian roadmap for chromosome 18. Proteomics 2011, 11, 1853-6.
2. Archakov, A.; Bergeron, J. J. M.; Khlunov, A.; Lisitsa, A.; Paik, Y.-K. The Moscow HUPO Human Proteome Project workshop. Mol. Cell. Proteomics 2009, 8, 2199-200.
3. Ivanov, Y. D.; Govorun, V. M.; Bykov, V. A.; Archakov, A. I. Nanotechnologies in proteomics. Proteomics 2006, 6, 1399-414.
4. Archakov, A. I.; Ivanov, Y. D.; Lisitsa, A. V.; Zgoda, V. G. AFM fishing nanotechnology is the way to reverse the Avogadro number in proteomics. Proteomics 2007, 7, 4-9.
5. Archakov, A.; Ivanov, Y.; Lisitsa, A.; Zgoda, V. Biospecific irreversible fishing coupled with atomic force microscopy for detection of extremely low-abundant proteins. Proteomics 2009, 9, 1326-43.
6. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B. B.; Simpson, R. J.; Eddes, J. S.; Kapp, E. A.; Moritz, R. L.; Chan, D. W.; Rai, A. J.; Admon, A.; Aebersold, R.; Eng, J.; Hancock, W. S.; Hefta, S. A.; Meyer, H.; Paik, Y.-K.; Yoo, J.-S.; Ping, P.; Pounds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C. Y.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D. W.; Hanash, S. M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-45.
7. Omenn, G. S.; Baker, M. S.; Aebersold, R. Recent Workshops of the HUPO Human Plasma Proteome Project (HPPP): a bridge with the HUPO CardioVascular Initiative and the emergence of SRM targeted proteomics. Proteomics 2011, 11, 3439-43.
8. States, D. J.; Omenn, G. S.; Blackwell, T. W.; Fermin, D.; Eng, J.; Speicher, D. W.; Hanash, S. M. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nature Biotechnol. 2006, 24, 333-8.
9. He, F. Human liver proteome project: plan, progress, and perspectives. Mol. Cell. Proteomics 2005, 4, 1841-8.
10. Elortza, F.; Beretta, L.; Zhang, X.; He, F.; Mato, J. M. The 2011 Human Liver Proteome Project (HLPP) Workshop September 5, 2011, Geneva, Switzerland. Proteomics 2012, 12, 5-8.
11. Zgoda, V. G.; Moshkovskii, S. A.; Ponomarenko, E. A.; Andreewski, T. V.; Kopylov, A. T.; Tikhonova, O. V.; Melnik, S. A.; Lisitsa, A. V.; Archakov, A. I. Proteomics of mouse liver microsomes: performance of different protein separation workflows for LC-MS/MS. Proteomics 2009, 9, 4102-5.
12. Lisitsa, A. V.; Petushkova, N. A.; Thiele, H.; Moshkovskii, S. A.; Zgoda, V. G.; Karuzina, I. I.; Chernobrovkin, A. L.; Skipenko, O. G.; Archakov, A. I. Application of slicing of one-dimensional gels with subsequent slice-by-slice mass spectrometry for the proteomic profiling of human liver cytochromes P450. J. Proteome Res. 2010, 9, 95-103.
13. Petushkova, N. A.; Kanaeva, I. P.; Lisitsa, A. V.; Sheremetyeva, G. F.; Zgoda, V. G.; Samenkova, N. F.; Karuzina, I. I.; Archakov, A. I. Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches. Toxicol. in Vitro 2006, 20, 966-74.
14. Zgoda, V.; Tikhonova, O.; Viglinskaya, A.; Serebriakova, M.; Lisitsa, A.; Archakov, A. Proteomic profiles of induced hepatotoxicity at the subcellular level. Proteomics 2006, 6, 4662-70.
15. Mee, C. J.; Harris, H. J.; Farquhar, M. J.; Wilson, G.; Reynolds, G.; Davis, C.; van IJzendoorn, S. C. D.; Balfe, P.; McKeating, J. A. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J. Virol. 2009, 83, 6211-21.
16. Slany, A.; Haudek, V. J.; Zwickl, H.; Gundacker, N. C.; Grusch, M.; Weiss, T. S.; Seir, K.; Rodgarkia-Dara, C.; Hellerbrand, C.; Gerner, C. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J. Proteome Res. 2010, 9, 6-21.
17. Geiger, T.; Wehner, A.; Schaab, C.; Cox, J.; Mann, M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell. Proteomics 2012, 11, No. M111.014050.
18. Anderson, N. L.; Polanski, M.; Pieper, R.; Gatlin, T.; Tirumalai, R. S.; Conrads, T. P.; Veenstra, T. D.; Adkins, J. N.; Pounds, J. G.; Fagan, R.; Lobley, A. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3, 311-26.
19. Archakov, A.; Zgoda, V.; Kopylov, A.; Naryzhny, S.; Chernobrovkin, A.; Ponomarenko, E.; Lisitsa, A. Chromosome-centric Approach to Overcoming Bottlenecks in the Human Proteome Project. Expert Rev. Proteomics 2012.
20. Kopylov, A. T.; Zgoda, V. G.; Lisitsa, A. V.; Archakov, A. I. Combining use of irreversible binding and multiple reactions monitoring technology for low-and ultralow copy-number proteins detection and quantitation. Proteomics 2012, in press.
21. Kolker, E.; Higdon, R.; Haynes, W.; Welch, D.; Broomall, W.; Lancet, D.; Stanberry, L.; et al. MOPED: Model Organism Protein Expression Database. Nucleic Acids Res. 2012, 40, 1093-9.
22. Schaab, C.; Geiger, T.; Stoehr, G.; Cox, J.; Mann, M. Analysis of high accuracy, quantitative proteomics data in the MaxQB database. Mol. Cell. Proteomics 2012, 11 (3), No. M111.014068.
23. Nagaraj, N.; Wisniewski, J. R.; Geiger, T.; Cox, J.; Kircher, M.; Kelso, J.; Pa?a?bo, S.; Mann, M. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 2011, 7, 548.
24. Paik, Y.-K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Marko-Varga, G.; Aebersold, R.; Bairoch, A.; Yamamoto, T.; Legrain, P.; Lee, H.-J.; Na, K.; Jeong, S.-K.; He, F.; Binz, P.-A.; Nishimura, T.; Keown, P.; Baker, M. S.; Yoo, J. S.; Garin, J.; Archakov, A.; Bergeron, J.; Salekdeh, G. H.; Hancock, W. S. Standard guidelines for the chromosomecentric human proteome project. J. Proteome Res. 2012, 11, 2005-13.
25. Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control. Nature 2011, 473, 337-42.
26. Lundberg, E.; Fagerberg, L.; Klevebring, D.; Matic, I.; Geiger, T.; Cox, J.; Algenas, C.; Lundeberg, J.; Mann, M.; Uhlen, M. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6, 450.
27. Nolan, T.; Hands, R. E.; Bustin, S. A. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 2006, 1, 1559-82.
28. Wilkening, S.; Stahl, F.; Bader, A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 2003, 31, 1035-42.
29. Buneeva, O.; Gnedenko, O.; Zgoda, V.; Kopylov, A.; Glover, V.; Ivanov, A.; Medvedev, A.; Archakov, A. Isatin-binding proteins of rat and mouse brain: proteomic identification and optical biosensor validation. Proteomics 2010, 10, 23-37.
30. Medvedev, A.; Kopylov, A.; Buneeva, O.; Zgoda, V.; Archakov, A. Affinity-based proteomic profiling: problems and achievements. Proteomics 2012, 12, 621-37.
31. Medvedev, A.; Igosheva, N.; Crumeyrolle-Arias, M.; Glover, V. Isatin: role in stress and anxiety. Stress (Amsterdam, Netherlands) 2005, 8, 175-83.
32. Medvedev, A.; Buneeva, O.; Glover, V. Biological targets for isatin and its analogues: Implications for therapy. Biol.: Targets Ther. 2007, 1, 151-62.
33. Ivanov, A. S.; Gnedenko, O. V.; Molnar, A. A.; Mezentsev, Y. V.; Lisitsa, A. V.; Archakov, A. I. Protein-protein interactions as new targets for drug design: virtual and experimental approaches. J. Bioinform. Comput. Biol. 2007, 5, 579-92.
34. Ponomarenko, E. A.; Poverennaya, E. V.; Pyatnitskiy, M. A.; Lisitsa, A. V.; Moshkovskii, S. A.; Ilgisonis, E. V.; Chernobrovkin, A. L.; Archakov, A. I. Comparative ranking of human chromosomes based on post-genomic data. OMICS JIB 2012, 16 (11), 604-11.
35. Lane, J.; Duroux, P.; Lefranc, M.-P. From IMGT-ONTOLOGY to IMGT/LIGMotif: the IMGT standardized approach for immunoglobulin and T cell receptor gene identification and description in large genomic sequences. BMC Bioinform. 2010, 11, 223.
36. Uhle?n, M.; Oksvold, P.; A?lgena?s, C.; Hamsten, C.; Fagerberg, L.; Klevebring, D.; Lundberg, E.; Odeberg, J.; Ponte?n, F.; Kondo, T.; Sivertsson, å. Antibody-based protein profiling of the human chromosome 21. Mol. Cell. Proteomics 2012, 11, No. M111.013458.
37. Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W.; et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921.
38. Hebenstreit, D.; Fang, M.; Gu, M.; Charoensawan, V.; van Oudenaarden, A.; Teichmann, S. A. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 2011, 7, 497.
39. Chen, H.; Liu, Z.; Gong, S.; Wu, X.; Taylor, W. L.; Williams, R. W.; Matta, S. G.; Sharp, B. M. Genome-wide gene expression profiling of nucleus accumbens neurons projecting to ventral pallidum using both microarray and transcriptome sequencing. Front. Neurosci. 2011, 5, 98.
40. Paik, Y.-K.; Jeong, S.-K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Cho, S. Y.; Lee, H.-J.; Na, K.; Choi, E.-Y.; Yan, F.; Zhang, F.; Zhang, Y.; Snyder, M.; Cheng, Y.; Chen, R.; Marko-Varga, G.; Deutsch, E. W.; Kim, H.; Kwon, J.-Y.; Aebersold, R.; Bairoch, A.; Taylor, A. D.; Kim, K. Y.; Lee, E.-Y.; Hochstrasser, D.; Legrain, P.; Hancock, W. S. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat. Biotechnol. 2012, 30, 221-3.
41. Picotti, P.; Rinner, O.; Stallmach, R.; Dautel, F.; Farrah, T.; Domon, B.; Wenschuh, H.; Aebersold, R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat. Methods 2010, 7, 43-6.
42. Sherwood, C. A.; Eastham, A.; Lee, L. W.; Peterson, A.; Eng, J. K.; Shteynberg, D.; Mendoza, L.; Deutsch, E. W.; Risler, J.; Tasman, N.; Aebersold, R.; Lam, H.; Martin, D. B. MaRiMba: a software application for spectral library-based MRM transition list assembly. J. Proteome Res. 2009, 8, 4396-405.
43. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-9.
44. Ivanov, A. S.; Zgoda, V. G.; Archakov, A. I. Technologies of Protein Interactomics: A Review. Russian Journal of Bioorganic Chemistry 2011, 37, 4-16.
45. Redondo, P. C.; Harper, M. T.; Rosado, J. A.; Sage, S. O. A role for cofilin in the activation of store-operated calcium entry by de novo conformational coupling in human platelets. Blood 2006, 107 (3), 973-9.
46. Hevi, S.; Chuck, S. L. Ferritins can regulate the secretion of apolipoprotein b. J. Biol. Chem. 2003, 278, 31924-9.
47. Polanski, M.; Anderson, N. L. A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights 2007, 1, 1-48.
48. Zhang, Z.; Bast, R. C.; Yu, Y.; Li, J.; Sokoll, L. J.; Rai, A. J.; Rosenzweig, J. M.; Cameron, B.; Wang, Y. Y.; Meng, X.-Y.; Berchuck, A.; Van Haaften-Day, C.; Hacker, N. F.; de Bruijn, H. W. A.; van der Zee, A. G. J.; Jacobs, I. J.; Fung, E. T.; Chan, D. W. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-90.
49. Moshkovskii, S. A.; Vlasova, M. A.; Pyatnitskiy, M. A.; Tikhonova, O. V.; Safarova, M. R.; Makarov, O. V.; Archakov, A. I. Acute phase serum amyloid A in ovarian cancer as an important component of proteome diagnostic profiling. Proteomics-Clin. Appl. 2007, 1, 107-17.
50. Yurkovetsky, Z.; Skates, S.; Lomakin, A.; Nolen, B.; Pulsipher, T.; Modugno, F.; Marks, J.; Godwin, A.; Gorelik, E.; Jacobs, I.; Menon, U.; Lu, K.; Badgwell, D.; Bast, R. C.; Lokshin, A. E. Development of a multimarker assay for early detection of ovarian cancer. J. Clin. Oncol. 2010, 28, 2159-66.
51. Cima, I.; Schiess, R.; Wild, P.; Kaelin, M.; Schu?ffler, P.; Lange, V.; Picotti, P.; Ossola, R.; Templeton, A.; Schubert, O.; Fuchs, T.; Leippold, T.; Wyler, S.; Zehetner, J.; Jochum, W.; Buhmann, J.; Cerny, T.; Moch, H.; Gillessen, S.; Aebersold, R.; Krek, W. Cancer geneticsguided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 3342-7.
52. Huttenhain, R.; Soste, M.; Selevsek, N.; Rost, H.; Sethi, A.; Carapito, C.; Farrah, T.; Deutsch, E. W.; Kusebauch, U.; Moritz, R. L.; Nimeus-Malmstrom, E.; Rinner, O.; Aebersold, R. Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics. Sci. Transl. Med. 2012, 4, 142ra94.
53. Auffray, C.; Hood, L. Editorial: Systems biology and personalized medicine-the future is now. Biotechnol. J. 2012, 7, 938-9.
54. Sachidanandam, R.; Weissman, D.; Schmidt, S. C.; Kakol, J. M.; Stein, L. D.; Marth, G.; Sherry, S.; Mullikin, J. C.; Mortimore, B. J.; Willey, D. L.; Hunt, S. E.; Cole, C. G.; Coggill, P. C.; Rice, C. M.; Ning, Z.; Rogers, J.; Bentley, D. R.; Kwok, P. Y.; Mardis, E. R.; Yeh, R. T.; Schultz, B.; Cook, L.; Davenport, R.; Dante, M.; Fulton, L.; Hillier, L.; Waterston, R. H.; McPherson, J. D.; Gilman, B.; Schaffner, S.; Van Etten, W. J.; Reich, D.; Higgins, J.; Daly, M. J.; Blumenstiel, B.; Baldwin, J.; Stange-Thomann, N.; Zody, M. C.; Linton, L.; Lander, E. S.; Altshuler, D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409, 928-33.
55. Rajaraman, P.; Melin, B. S.; Wang, Z.; McKean-Cowdin, R.; Michaud, D. S.; Wang, S. S.; Bondy, M.; Houlston, R.; Jenkins, R. B.; Wrensch, M.; Yeager, M.; Ahlbom, A.; Albanes, D.; Andersson, U.; Freeman, L. E. B.; Buring, J. E.; Butler, M. A.; Braganza, M.; Carreon, T.; Feychting, M.; Fleming, S. J.; Gapstur, S. M.; Gaziano, J. M.; Giles, G. G.; Hallmans, G.; Henriksson, R.; Hoffman-Bolton, J.; Inskip, P. D.; Johansen, C.; Kitahara, C. M.; Lathrop, M.; Liu, C.; Le Marchand, L.; Linet, M. S.; Lonn, S.; Peters, U.; Purdue, M. P.; Rothman, N.; Ruder, A. M.; Sanson, M.; Sesso, H. D.; Severi, G.; Shu, X.-O.; Simon, M.; Stampfer, M.; Stevens, V. L.; Visvanathan, K.; White, E.; Wolk, A.; Zeleniuch-Jacquotte, A.; Zheng, W.; Decker, P.; Enciso-Mora, V.; Fridley, B.; Gao, Y.-T.; Kosel, M.; Lachance, D. H.; Lau, C.; Rice, T.; Swerdlow, A.; Wiemels, J. L.; Wiencke, J. K.; Shete, S.; Xiang, Y.-B.; Xiao, Y.; Hoover, R. N.; Fraumeni, J. F.; Chatterjee, N.; Hartge, P.; Chanock, S. J. Genome-wide association study of glioma and metaanalysis. Hum. Genet. 2012, 131 (12), 1877-88.
56. Tomlins, S. A.; Rhodes, D. R.; Perner, S.; Dhanasekaran, S. M.; Mehra, R.; Sun, X. W.; Varambally, S.; Cao, X.; Tchinda, J.; Kuefer, R.; Lee, C.; Montie, J. E.; Shah, R. B.; Pienta, K. J.; Rubin, M. A.; Chinnaiyan, A. M. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310, 644-8.
57. Wishner, B. C.; Ward, K. B.; Lattman, E. E.; Love, W. E. Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution. J. Mol. Biol. 1975, 98, 179-94.
58. Hardy, J. Framing beta-amyloid. Nat. Genet. 1992, 4, 233-4.
59. Su, Z.-D.; Sun, L.; Yu, D.-X.; Li, R.-X.; Li, H.-X.; Yu, Z.-J.; Sheng, Q.-H.; Lin, X.; Zeng, R.; Wu, J.-R. Quantitative detection of single amino acid polymorphisms by targeted proteomics. J. Mol. Cell Biol. 2011, 3, 309-15.
60. Omenn, G. S.; Yocum, A. K.; Menon, R. Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications. Dis. Markers 2010, 28, 241-51.
61. Blakeley, P.; Siepen, J. A.; Lawless, C.; Hubbard, S. J. Investigating protein isoforms via proteomics: a feasibility study. Proteomics 2010, 10, 1127-40.